Eisai Files Marketing Authorization Application for Anti-Amyloid-Beta Protofibril Antibody Lecanemab for Early Alzheimer’s Disease in Japan
TOKYO and CAMBRIDGE, Mass […]
TOKYO and CAMBRIDGE, Mass […]
NEW YORK, NY, Jan 16, 202 […]
ROCKVILLE, MD and SHENZHE […]
ROCKVILLE, MD and SHENZHE […]
HONG KONG, Oct 28, 2022 & […]
HONG KONG, Sep 15, 2022 & […]
HONG KONG, Aug 24, 2022 & […]
Continuously expanding th […]
Singapore, Mar 25, 2022 & […]
HONG KONG, Mar 14, 2022 & […]
HONG KONG, Feb 17, 2022 & […]
TOKYO, Dec 21, 2021 ̵ […]
TOKYO, Dec 20, 2021 ̵ […]
Singapore, Dec 2, 2021 &# […]
TOKYO, Nov 11, 2021 ̵ […]
TOKYO, Oct 19, 2021 ̵ […]
– Gradiant demonstrated s […]
MELBOURNE, Sep 6, 2021 &# […]
TOKYO, Jul 30, 2021 ̵ […]
TOKYO, Jul 27, 2021 ̵ […]
KUALA LUMPUR, Jun 9, 2021 […]
TOKYO, Apr 27, 2021 ̵ […]
SHANGHAI, CHINA, Apr 23, […]